Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Indiana Blood & Marrow Transplantation is a specialized hematology-oncology and transplant practice in Indianapolis, Indiana operating within Franciscan Health. The program provides adult autologous and allogeneic stem cell transplantation, immune effector cellular therapy including CAR-T cell therapy, apheresis and related outpatient cancer services for patients with blood cancers and other serious hematologic disorders. IBMT appears to function primarily as a clinical care delivery organization rather than a drug-development biotech company. The program has operated for more than 25 years, is FACT accredited, and serves as one of the limited blood and marrow transplantation programs in Indiana. Its clinical focus includes leukemia, lymphoma, multiple myeloma and other malignant blood disorders, with associated supportive and multidisciplinary care services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Indiana Blood & Marrow Transplantation.